piracetam has been researched along with dihydroergotoxine in 31 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 26 (83.87) | 18.7374 |
| 1990's | 4 (12.90) | 18.2507 |
| 2000's | 1 (3.23) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ban, TA; Petrie, WM | 1 |
| Briley, M; Chopin, P | 1 |
| Wade, JP | 1 |
| Laszy, J; Sarkadi, A | 1 |
| Carbayeda, M; Castro, C; Labella, T; Ordosgoitia, H | 1 |
| Iwai, A; Kawabata, S; Ozawa, Y; Shimizu, M; Yamamoto, M | 1 |
| Nistiarová, A; Tkácová, R; Tomori, Z | 1 |
| Jones, RS; Olpe, HR; Steinmann, MW | 1 |
| Ohtomo, E | 1 |
| Beckett, PR; Berga, P; Llenas, J; Massingham, R; Roberts, DJ | 1 |
| Hollister, LE | 1 |
| Andreas, K; Dienel, A; Schmidt, J | 1 |
| Jolles, J; Verhoeven, WM | 1 |
| Gertz, HJ; Kanowski, S | 1 |
| Spagnoli, A; Tognoni, G | 1 |
| Branconnier, RJ | 1 |
| Jänicke, B; Wrobel, D | 1 |
| Schmidt, J | 1 |
| Funk, KF; Schmidt, J | 1 |
| Jamieson, DD; Taylor, KM | 1 |
| Fischer, HD; Ranacher, B; Rudolph, E; Schmidt, J; Schwipper, U; Wustmann, C | 1 |
| Chang, T; Young, RM | 1 |
| Grünberger, J; Saletu, B | 1 |
| Ferris, SH; Gershon, S; Reisberg, B | 1 |
| Olpe, HR; Steinmann, MW | 2 |
| Dennler, HJ; Lukaschek, K; Matejcek, M; Oswald, B; Oswald, WD | 1 |
| Kent, S | 1 |
| Dietze, M; Fischer, HD; Rudolph, E; Schulze, S; Wustmann, C | 1 |
| Pons Rocher, F | 1 |
| Adler, G; Berger, FM; Calabrese, P; Frölich, L; Gertz, HJ; Hampel, H; Haupt, M; Jendroska, K; Kohler, J; Mielke, R; Paulus, HJ; Pilartz, H; Riepe, MW; Zedlick, D | 1 |
7 review(s) available for piracetam and dihydroergotoxine
| Article | Year |
|---|---|
Drugs in geropsychiatry.
Topics: Aged; Anticoagulants; Central Nervous System Agents; Dementia; Dihydroergotoxine; Humans; Hypnotics and Sedatives; Mental Disorders; Neurocognitive Disorders; Papaverine; Parasympathomimetics; Piracetam; Vasodilator Agents | 1978 |
Multi-infarct dementia: prevention and treatment.
Topics: Cerebrovascular Disorders; Dementia, Multi-Infarct; Dihydroergotoxine; Humans; Hypertension; Naloxone; Piracetam; Pyrrolidines | 1991 |
[Recent drug therapy of senile dementia].
Topics: Adrenocorticotropic Hormone; Alzheimer Disease; Choline; Dementia; Dihydroergotoxine; Humans; Narcotic Antagonists; Peptide Fragments; Phosphatidylcholines; Physostigmine; Piracetam; Pyrrolidines; Succinimides | 1987 |
[Psychopharmacologic treatment of cognitive function disorders in aging persons: current possibilities].
Topics: Adrenocorticotropic Hormone; Aged; Alzheimer Disease; Anticonvulsants; Brain; Catecholamines; Choline; Dementia; Dihydroergotoxine; Humans; Memory Disorders; Narcotic Antagonists; Nerve Tissue Proteins; Neuropsychology; Parasympatholytics; Phosphatidylcholines; Physostigmine; Piracetam; Trace Elements; Vasopressins; Vitamins | 1984 |
'Cerebroactive' drugs. Clinical pharmacology and therapeutic role in cerebrovascular disorders.
Topics: Adult; Aged; Cerebrovascular Disorders; Cinnarizine; Clinical Trials as Topic; Cytidine Diphosphate Choline; Dementia; Dihydroergotoxine; Humans; Middle Aged; Nafronyl; Pentoxifylline; Piracetam; Vasodilator Agents; Vincamine | 1983 |
The efficacy of the cerebral metabolic enhancers in the treatment of senile dementia.
Topics: Aged; Brain; Dementia; Dihydroergotoxine; Humans; Meclofenoxate; Nafronyl; Piracetam; Pyrithioxin; Vincamine | 1983 |
An overview of pharmacologic treatment of cognitive decline in the aged.
Topics: Anticoagulants; Clinical Trials as Topic; Cognition Disorders; Dihydroergotoxine; Humans; Hyperbaric Oxygenation; Methylphenidate; Parasympathomimetics; Peptides; Piracetam; Procaine; Vasodilator Agents | 1981 |
5 trial(s) available for piracetam and dihydroergotoxine
| Article | Year |
|---|---|
'Cerebroactive' drugs. Clinical pharmacology and therapeutic role in cerebrovascular disorders.
Topics: Adult; Aged; Cerebrovascular Disorders; Cinnarizine; Clinical Trials as Topic; Cytidine Diphosphate Choline; Dementia; Dihydroergotoxine; Humans; Middle Aged; Nafronyl; Pentoxifylline; Piracetam; Vasodilator Agents; Vincamine | 1983 |
Antihypoxidotic and nootropic drugs: proof of their encephalotropic and pharmacodynamic properties by quantitative EEG investigations.
Topics: Adult; Age Factors; Aged; Benzamides; Brain; Cinnarizine; Clinical Trials as Topic; Dihydroergotoxine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Combinations; Electroencephalography; Female; Hexobendine; Humans; Isoxsuprine; Levetiracetam; Male; Middle Aged; Nicergoline; Piracetam; Psychotropic Drugs; Theophylline; Time Factors | 1980 |
An overview of pharmacologic treatment of cognitive decline in the aged.
Topics: Anticoagulants; Clinical Trials as Topic; Cognition Disorders; Dihydroergotoxine; Humans; Hyperbaric Oxygenation; Methylphenidate; Parasympathomimetics; Peptides; Piracetam; Procaine; Vasodilator Agents | 1981 |
[On the meaning of psychometrically operationalized therapeutic effects in the treatment of brain insufficiency phenomena caused by old age demonstrated by the "Nürnberger-Alters-Inventar" (author's transl)].
Topics: Activities of Daily Living; Aged; Aging; Cognition; Dihydroergotoxine; Electroencephalography; Humans; Mental Disorders; Middle Aged; Piracetam; Psychometrics; Pyrrolidinones; Social Behavior | 1982 |
[The effect of pharmacological treatment in the compensation of vertigo].
Topics: Adolescent; Adrenergic alpha-Antagonists; Adult; Aged; Child; Dihydroergotoxine; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Neuroprotective Agents; Piracetam; Treatment Outcome; Vertigo | 1999 |
21 other study(ies) available for piracetam and dihydroergotoxine
| Article | Year |
|---|---|
Effects of four non-cholinergic cognitive enhancers in comparison with tacrine and galanthamine on scopolamine-induced amnesia in rats.
Topics: Amnesia; Animals; Avoidance Learning; Cognition; Dihydroergotoxine; Dose-Response Relationship, Drug; Galantamine; Ginkgo biloba; Male; Nicergoline; Piracetam; Plant Extracts; Rats; Rats, Inbred Strains; Scopolamine; Secologanin Tryptamine Alkaloids; Tacrine; Yohimbine | 1992 |
Hypoxia-induced sleep disturbance in rats.
Topics: Animals; Dihydroergotoxine; Disease Models, Animal; Hypoxia; Male; Piracetam; Rats; Sleep Stages; Sleep Wake Disorders | 1990 |
[Clinical trial of the use of the combination of piracetam and dihydroergocristine in vertigo from different causes].
Topics: Adult; Aged; Dihydroergotoxine; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Piracetam; Pyrrolidinones; Vertigo | 1989 |
Effects of indeloxazine hydrochloride on passive avoidance behavior of senescence-accelerated mice.
Topics: Aging; Animals; Antidepressive Agents; Avoidance Learning; Cognition; Cycloheximide; Dihydroergotoxine; Mice; Mice, Inbred ICR; Mice, Inbred Strains; Morpholines; Piracetam; Scopolamine | 1989 |
Anti-hypoxic potency of cerebroprotective drugs studied in a model of acute reversible respiratory failure.
Topics: Animals; Brain Ischemia; Cats; Dihydroergotoxine; Disease Models, Animal; Electrocardiography; Hypoxia; Nitrogen; Pentoxifylline; Piracetam; Respiration, Artificial; Respiratory Insufficiency | 1989 |
Locus coeruleus as a target for psychogeriatric agents.
Topics: Amphetamine; Animals; Caffeine; Cerebral Cortex; Dihydroergotoxine; Dose-Response Relationship, Drug; Learning; Locus Coeruleus; Male; Memory; Methylphenidate; Neural Pathways; Neurons; Piracetam; Rats; Rats, Inbred Strains; Receptors, Adrenergic; Septum Pellucidum; Vincamine | 1985 |
Synergistic interactions between piracetam and dihydroergocristine in some animal models of cerebral hypoxia and ischaemia.
Topics: Anesthesia; Animals; Avoidance Learning; Brain Ischemia; Cerebrovascular Circulation; Dihydroergotoxine; Dogs; Drug Synergism; Hemodynamics; Hypercapnia; Hypoxia, Brain; Magnesium; Magnesium Chloride; Male; Mice; Pentobarbital; Piracetam; Pyrrolidinones; Rats; Rats, Inbred Strains; Reflex | 1986 |
Alzheimer's disease. Is it worth treating?
Topics: Aged; Alzheimer Disease; Dementia; Dihydroergotoxine; Humans; Nafronyl; Papaverine; Pentoxifylline; Piracetam; Procaine; Psychotropic Drugs | 1985 |
Influence of nootropic drugs on drinking behaviour in ethanol-preferring mice and ethanol-induced increase of seizure susceptibility.
Topics: Alcohol Drinking; Alcoholism; Animals; Dihydroergotoxine; Ethanol; Male; Meglumine; Mice; Mice, Inbred ICR; Orotic Acid; Piracetam; Seizures; Substance Withdrawal Syndrome; Synapses; Trapidil | 1985 |
[Therapy of senile dementia of the Alzheimer type and multi-infarct dementia].
Topics: Alzheimer Disease; Animals; Brain; Cerebrovascular Circulation; Combined Modality Therapy; Dementia; Depressive Disorder; Dihydroergotoxine; Double-Blind Method; Energy Metabolism; Humans; Meclofenoxate; Neurotransmitter Agents; Piracetam; Psychotherapy; Pyrithioxin | 1983 |
Changes in motor activity with age and the effects of pharmacologic treatment.
Topics: Aging; Animals; Body Weight; Dextroamphetamine; Dihydroergotoxine; Female; Meclofenoxate; Motor Activity; Piracetam; Pyrithioxin; Pyrrolidinones; Rats; Rats, Inbred Strains | 1984 |
Nootropic drugs reduce immobility in behavioural despair test in mice.
Topics: Animals; Dihydroergotoxine; Male; Meclofenoxate; Meglumine; Mice; Motor Activity; Nicergoline; Orotic Acid; Piracetam; Psychotropic Drugs; Pyrithioxin; Vinca Alkaloids | 1984 |
Changes of dopamine metabolism by hypoxia and effect of nootropic drugs.
Topics: Animals; Brain; Caudate Nucleus; Diazepam; Dihydroergotoxine; Dopamine; Hypoxia; Meclofenoxate; Orotic Acid; Piracetam; Psychotropic Drugs; Pyrithioxin; Rats; Rats, Inbred Strains; Vinca Alkaloids | 1984 |
Effects of centrophenoxine, piracetam and hydergine on rat brain lipid peroxidation.
Topics: Aging; Animals; Brain; Dihydroergotoxine; Glycolates; In Vitro Techniques; Lipid Peroxides; Male; Meclofenoxate; Piracetam; Pyrrolidinones; Rats | 1981 |
[Effect of nootropic drugs on the dopamine release and dopamine uptake in structures of the rat striatum].
Topics: Animals; Brain; Dihydroergotoxine; Dopamine; Drug Interactions; Meclofenoxate; Meglumine; Orotic Acid; Piracetam; Psychotropic Drugs; Pyrithioxin; Rats; Rats, Inbred Strains | 1982 |
Gas chromatographic assay of pramiracetam in human plasma using nitrogen specific detection.
Topics: Chromatography, Gas; Dihydroergotoxine; Humans; Piracetam; Pyrrolidines; Time Factors; Vincamine | 1983 |
The effect of vincamine, hydergine and piracetam on the firing rate of locus coeruleus neurons.
Topics: Animals; Dihydroergotoxine; Dose-Response Relationship, Drug; Locus Coeruleus; Male; Neurons; Norepinephrine; Piracetam; Pyrrolidinones; Rats; Sleep; Vinca Alkaloids; Vincamine; Wakefulness | 1982 |
Preventing senile dementia: hope for the future.
Topics: Aged; Choline; Dementia; Dihydroergotoxine; Female; Humans; Male; Memory; Middle Aged; Piracetam | 1981 |
[Effect of piracetam and dihydroergotoxine on the release of dopamine from the corpus striatum of the rat].
Topics: Animals; Corpus Striatum; Dihydroergotoxine; Dopamine; Piracetam; Pyrrolidinones; Rats | 1980 |
Rapid communication the activating activity of vincamine, piracetam, and hydergine on the activity of the noradrenergic neurons of the locus coeruleus.
Topics: Animals; Dihydroergotoxine; Evoked Potentials; Locus Coeruleus; Male; Neurons; Norepinephrine; Piracetam; Pyrrolidinones; Rats; Rats, Inbred Strains; Vinca Alkaloids; Vincamine | 1981 |
[Early diagnosis and treatment of Alzheimer's disease. Implementation in the doctor's office].
Topics: Aged; Alzheimer Disease; Brief Psychiatric Rating Scale; Carbamates; Cholinesterase Inhibitors; Dihydroergotoxine; Donepezil; Family Practice; Female; Follow-Up Studies; Galantamine; Ginkgo biloba; Humans; Indans; Male; Memantine; Neuroprotective Agents; Nimodipine; Nootropic Agents; Phenylcarbamates; Piperidines; Piracetam; Psychiatric Status Rating Scales; Risk Factors; Rivastigmine; Time Factors; Vasodilator Agents | 2002 |